PMID: 9001565Nov 1, 1996Paper

Carcinoembryonic antigen as a target for cancer vaccines

Cancer Immunology, Immunotherapy : CII
J W Hodge

Abstract

The vaccine approach to cancer therapy is still in the early stages. Since any immune response has a limited capacity, immunotherapeutic manipulations to destroy tumor will probably be most effective against small tumor masses or micrometastases. Consequently, immunotherapy with these CEA cancer vaccines may prove most effective in the adjuvant setting, where disease has been controlled or stabilized with conventional therapies. The development of CEA cancer vaccines involves many parameters, including the appropriate form of the vaccine, i.e., recombinant protein, peptides, vectors etc., the use of classical adjuvants and/or biological adjuvants such as cytokines, and the use of T cell costimulatory molecules. The integration of these parameters into the development of a cancer vaccine will be the challenge for the next decade [33].

Citations

Sep 8, 2000·Bulletin of Experimental Biology and Medicine·B S AmandzholovF V Donenko
Sep 8, 2000·Bulletin of Experimental Biology and Medicine·S M SitdikovaF V Donenko
Jul 21, 2005·Cancer Immunology, Immunotherapy : CII·Min Yu, Olivera J Finn
Dec 23, 2006·Cancer Immunology, Immunotherapy : CII·Ying-Hua LanHong Ren
Mar 5, 2004·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Angelo AquinoEnzo Bonmassar
Nov 22, 1997·Current Opinion in Immunology·B J Van den Eynde, P van der Bruggen
Feb 19, 2000·Current Opinion in Immunology·S I Abrams, J Schlom
May 16, 2002·International Immunopharmacology·Salvatore P PreteAngelo Aquino
Oct 1, 2013·Current Opinion in Oncology·Carmen Criscitiello, Giuseppe Curigliano
Jul 29, 2004·Journal of Virology·Andrea FacciabeneNicola La Monica
Oct 16, 2001·Drugs & Aging·S Matzku, M Zöller
Jan 1, 2012·The Journal of IMA·Soumen DasMrityunjay Mukherjee
Sep 23, 2008·Expert Opinion on Pharmacotherapy·Peng H Tan, Amrit S Lota
Mar 14, 2002·Expert Opinion on Biological Therapy·Michael L Salgaller
May 19, 2006·Expert Opinion on Biological Therapy·Alberto Pinzon-CharryJosé Alejandro López
Nov 4, 2000·Expert Opinion on Investigational Drugs·L A Jones, M L Salgaller
Oct 26, 1999·Immunobiology·M Zöller, S Matzku
Apr 23, 2015·Human Vaccines & Immunotherapeutics·Sang-Yeul Lee, Jeong-Im Sin
Sep 1, 2007·Cancer·Elizabeth A MittendorfS Eva Singletary
Apr 13, 2012·International Journal of Cancer. Journal International Du Cancer·Aws Abdul-WahidJean Gariépy
Jun 22, 2005·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Salvatore Pasquale PreteAngelo Aquino
Nov 16, 2004·Surgical Oncology Clinics of North America·Michael S Sabel, Matthew A Nehs
Aug 2, 2013·Breast Care·Carmen Criscitiello
Aug 12, 2003·Expert Review of Vaccines·Emina H Huang, Howard L Kaufman
Jun 10, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Mala ChakrabortyJames W Hodge
Mar 16, 2001·Breast Cancer Research : BCR·M J Scanlan, D Jäger
Feb 15, 2003·Gynecologic Oncology·James W HodgeJeffrey Schlom

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.